Why do immune cells that are supposed to eliminate viruses suddenly turn against our own body? There are instances where killer T cells—which are meant to precisely remove virus-infected ...

Glioblastoma (GBM), the most aggressive primary brain tumor, continues to portend a poor prognosis with median survival under two years, despite standard care involving surgery, radiation, and ...

A new systematic review shows CAR T-cell therapy delivers high remission rates, reduced disease activity, and low toxicity in ...

According to researchers, IL-15 triggers harmful T-cell activation, but the calcineurin–NFAT pathway acts as a brake, ...

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of ...

Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, increasing cytotoxic ...

According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...

Scientists from Tianjin University have made a groundbreaking advancement in cancer therapeutics by developing an oral "microbial fuel cell" capsule. This innovative platform, activated by ...